Status:

UNKNOWN

Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients

Lead Sponsor:

Federal University of Rio Grande do Sul

Collaborating Sponsors:

AC Camargo Cancer Center

Instituto do Cancer do Estado de São Paulo

Conditions:

Mucositis

Xerostomia

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Head and neck cancer (HNC) are among the most frequent malignancies in the world. The main treatment modalities for HNC are surgical excision, radiotherapy (RT), and chemotherapy (CT). Severe oral seq...

Detailed Description

Radiotherapy (RT) and chemotherapy-induced oral side effects, as oral mucositis, and xerostomia are extremely challenging for professionals in the supportive care for head and neck squamous cell carci...

Eligibility Criteria

Inclusion

  • Patients with a diagnosis of cancer in the oral cavity and oropharynx any clinical stage based on TNM staging of head and neck cancer;
  • Patients who received oral care prior to oncological treatment;
  • Patients who will receive conformational radiotherapy (RT-C3D) or Intensity-modulated radiotherapy (IMRT) from 50 Gy to 70 Gy (primary radiation field) in daily doses of 1.8-2, 12 Gy divided five times per week (from Monday to Friday), totalizing 6 to 7 weeks of treatment. They may receive exclusive RT or with chemotherapy concomitant with cisplatin (100 mg/m2 every 21 days or 50 mg/m2 per week);
  • Patients feeding orally or by parenteral nutrition;
  • Patients who agree to participate in the study after reading, filling, and signing the Consent Form for Participation in Clinical Research.

Exclusion

  • Patients who develop head and neck radiodermatitis and for this reason interrupt the survey;
  • Patients who do not appear in four or more PBMT or RT sessions.

Key Trial Info

Start Date :

March 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2024

Estimated Enrollment :

132 Patients enrolled

Trial Details

Trial ID

NCT05242991

Start Date

March 1 2021

End Date

October 1 2024

Last Update

March 9 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Federal University of Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, Brazil